UNSPSC 51386605: Diperodon/hydrocortisone/zinc oxide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE200. This VA Drug Class (DE200) classifies this compound as belonging to the group ANTI-INFLAMMATORY, TOPICAL.

UNSPSC 51386605 Diperodon/hydrocortisone/zinc oxide is a Commodity code that does not reflect the actual work being solicited under it in recent state and local procurement. The single recent opportunity posted under this code is Seminole County, Florida's IFB 60459723LAS for naloxone and drug deactivation systems — a pharmaceutical supply and harm-reduction procurement entirely unrelated to the topical dermatological compound the code nominates. State and local governments do not appear to be actively procuring diperodon/hydrocortisone/zinc oxide compounds under this code at present.

The mismatch between the code's stated scope and the actual procurement activity suggests either a tagging error in the sourcing system or that the code is dormant for state and local buyers. The Seminole County solicitation stands as the only recent record; it sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, Sanford, Florida, through an IFB with a response deadline of July 26, 2023. Without additional recent opportunities correctly mapped to this commodity code, there is insufficient signal to characterize either the issuing-body mix or the geographic distribution of procurement activity. Firms should verify code assignment before investing pursuit resources.